ClearCount Medical has developed the SmartSponge and SmartWand systems, which use radio-frequency identification (RFID) technology and chips embedded in sponges to allow surgeons and nurses to detect and count sponges during operations.
ClearCount’s latest funding comes in the form of options and debt and was sourced from one investor, according to the regulatory filing.
Surgical sponges are the most frequent and dangerous “retained surgical items” (RSIs) that are mistakenly left inside patients.
ClearCount says its products can reduce or eliminate preventable hospital costs and delays associated with RSIs, including additional surgery and infection costs, litigation and unnecessary X-rays.
Earlier this year, ClearCount released a new product, the SmartSponge Flex, which features improved design for OR use, according to the company.
ClearCount has at least two major competitors that take different approaches to surgical sponge detection: SurgiCount Medical uses bar-coding technology and RF Surgical Systems uses electronic surveillance technology.
ClearCount CEO David Palmer didn’t immediately return a call.